Health
Study shows reliability and robustness of injectable anti-obesity medication – News-Medical.Net
A second study of the injectable anti-obesity medication, semaglutide, has confirmed the large weight losses reported in a study earlier this month, establishing…

A second study of the injectable anti-obesity medication, semaglutide, has confirmed the large weight losses reported in a study earlier this month, establishing the reliability and robustness of this new drug. With obesity affecting more than 40 percent of American adults, the findings could have a major impact on weight management in primary care and other settings. The study is published today in the Journal of the American Medical Association.
The 68-week study was conducted at 41 sites in the…
-
Noosa News24 hours ago
How a 3D printed aorta helped surgeons replace a ‘ticking time bomb’ inside a man’s chest
-
Noosa News21 hours ago
Ensure voices are heard – Proctor
-
General22 hours ago
Reserve Bank board still looking for yesterday’s news
-
Noosa News16 hours ago
Major crash on Gateway Motorway snarls morning commute